QR-koodi

Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation

Sodium glucose cotransporter 2 inhibitors (SGLT2i) are standard of care for type 2 diabetes mellitus, heart failure, and chronic kidney disease (CKD). Heart transplant (HTx) recipients are at increased risk of diabetes and CKD, and both are independently associated with increased mortality. In a ret...

Täydet tiedot

Tallennettuna:
Päätekijät: Lisa M. Raven, MBBS, FRACP, Jerry R. Greenfield, MBBS (Hons 1), PhD, FRACP, Andrew Jabbour, BSc (Med), MBBS (Hons), PhD, FRACP, Peter S. Macdonald, MBBS, MD, PhD, FRACP, Christopher A. Muir, MBBS (Hons), FRACP, PhD
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2025-05-01
Sarja:JHLT Open
Aiheet:
SGLT2
sodium glucose cotransporter 2
heart transplant
transplantation
kidney
renal
Linkit:http://www.sciencedirect.com/science/article/pii/S2950133425000503
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia